NO953989D0 - Nye polysykliske systemer og derivater derav, som neurotransmitter frigivelses-forsökende midler som er anvendbare ved behandling av kognitive sykdommer - Google Patents

Nye polysykliske systemer og derivater derav, som neurotransmitter frigivelses-forsökende midler som er anvendbare ved behandling av kognitive sykdommer

Info

Publication number
NO953989D0
NO953989D0 NO953989A NO953989A NO953989D0 NO 953989 D0 NO953989 D0 NO 953989D0 NO 953989 A NO953989 A NO 953989A NO 953989 A NO953989 A NO 953989A NO 953989 D0 NO953989 D0 NO 953989D0
Authority
NO
Norway
Prior art keywords
derivatives
treatment
agents useful
cognitive disorders
neurotransmitter release
Prior art date
Application number
NO953989A
Other languages
English (en)
Other versions
NO953989L (no
NO308745B1 (no
Inventor
Christopher Allan Teleha
Wendell Wilkie Wilkerson
Richard Alan Earl
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/216,881 external-priority patent/US5594001A/en
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of NO953989D0 publication Critical patent/NO953989D0/no
Publication of NO953989L publication Critical patent/NO953989L/no
Publication of NO308745B1 publication Critical patent/NO308745B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Steroid Compounds (AREA)
NO953989A 1993-04-08 1995-10-06 Nye, polycykliske forbindelser samt preparater inneholdende disse NO308745B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4401293A 1993-04-08 1993-04-08
US08/216,881 US5594001A (en) 1993-04-08 1994-03-28 Polycyclic systems, and derivatives thereof, as neurotransmitter release enhancers useful in the treatment of cognitive disorders
PCT/US1994/003673 WO1994024131A1 (en) 1993-04-08 1994-04-04 Novel polycyclic systems, and derivatives thereof, as neurotransmitter release enhancer useful in the treatment of cognitive disorders

Publications (3)

Publication Number Publication Date
NO953989D0 true NO953989D0 (no) 1995-10-06
NO953989L NO953989L (no) 1995-12-07
NO308745B1 NO308745B1 (no) 2000-10-23

Family

ID=26721086

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953989A NO308745B1 (no) 1993-04-08 1995-10-06 Nye, polycykliske forbindelser samt preparater inneholdende disse

Country Status (21)

Country Link
US (1) US5990132A (no)
EP (1) EP0693069A1 (no)
JP (1) JPH08509713A (no)
CN (2) CN1058495C (no)
AU (1) AU690906B2 (no)
BR (1) BR9405954A (no)
CA (1) CA2160112A1 (no)
CZ (1) CZ251995A3 (no)
FI (1) FI954775A0 (no)
HU (1) HUT74104A (no)
IL (1) IL109237A (no)
LV (1) LV11179B (no)
NO (1) NO308745B1 (no)
NZ (1) NZ265183A (no)
OA (1) OA10235A (no)
PL (1) PL178570B1 (no)
RO (1) RO115162B1 (no)
RU (1) RU2152944C1 (no)
SI (1) SI9420022A (no)
SK (1) SK124695A3 (no)
WO (1) WO1994024131A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750528A (en) * 1995-02-01 1998-05-12 The Dupont Merck Pharmaceutical Company Blockade of neuronal m-channels as a therapeutic approach to the treatment of neurological disease
US6262081B1 (en) * 1998-07-10 2001-07-17 Dupont Pharmaceuticals Company Composition for and method of treating neurological disorders
JP5581607B2 (ja) * 2008-06-05 2014-09-03 住友化学株式会社 高分子化合物及びそれを用いた有機トランジスタ
EP2909204B1 (en) 2012-10-12 2018-12-05 The Broad Institute, Inc. Gsk3 inhibitors and methods of use thereof
WO2014084612A1 (ko) 2012-11-30 2014-06-05 주식회사 엘지화학 신규한 화합물 및 이를 이용한 유기 전자 소자
WO2015027015A1 (en) 2013-08-22 2015-02-26 Bristol-Myers Squibb Company Imidazole-derived modulators of the glucocorticoid receptor
US9593113B2 (en) 2013-08-22 2017-03-14 Bristol-Myers Squibb Company Imide and acylurea derivatives as modulators of the glucocorticoid receptor
KR101723997B1 (ko) * 2014-02-05 2017-04-06 브이엠 온콜로지 엘엘씨 화합물의 조성물 및 이의 용도
GB201417369D0 (en) * 2014-10-01 2014-11-12 Redx Pharma Ltd Compounds
CN109863139B (zh) * 2016-11-07 2023-02-17 范德比尔特大学 毒蕈碱型乙酰胆碱受体m4的正向别构调节剂
US11203601B2 (en) 2017-04-05 2021-12-21 The Broad Institute, Inc. Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1052346A (no) * 1964-09-09
US4760083A (en) * 1986-04-10 1988-07-26 E. I. Dupont De Nemours & Company 3,3-disubstituted indolines
US5173489A (en) * 1986-04-10 1992-12-22 The Dupont Merck Pharmaceutical Co. α,α-disubstituted aromatics and heteroaromatics as cognition enhancers
US6194439B1 (en) * 1991-05-29 2001-02-27 Pfizer Inc. Tricyclic polyhydroxylic tyrosine kinase inhibitors
US5272269A (en) * 1992-01-16 1993-12-21 The Du Pont Merck Pharmaceutical Company Disubstituted polycyclic systems and preparative methods therefor
RU2051151C1 (ru) * 1992-01-16 1995-12-27 Дзе Дюпон Мерк Фармасьютикал Компани Азотсодержащие гетероциклические производные флуорена
EP0623127B1 (en) * 1992-01-16 1997-04-02 The Du Pont Merck Pharmaceutical Company Novel neurotransmitter releasers useful for cognition enhancement
US5185447A (en) * 1992-01-29 1993-02-09 Du Pont Merck Pharmaceutical Company Polycyclic ketones and preparative methods therefor
US5359070A (en) * 1993-02-11 1994-10-25 The Du Pont Merck Pharmaceutical Company Unsymmetrical bis-imides as anticancer agents

Also Published As

Publication number Publication date
CZ251995A3 (en) 1996-01-17
SI9420022A (en) 1996-10-31
JPH08509713A (ja) 1996-10-15
LV11179A (lv) 1996-04-20
HU9502929D0 (en) 1995-11-28
CN1122135A (zh) 1996-05-08
IL109237A (en) 1998-02-08
FI954775A (fi) 1995-10-06
OA10235A (en) 1997-10-07
CN1058495C (zh) 2000-11-15
WO1994024131A1 (en) 1994-10-27
FI954775A0 (fi) 1995-10-06
RO115162B1 (ro) 1999-11-30
IL109237A0 (en) 1994-07-31
RU2152944C1 (ru) 2000-07-20
BR9405954A (pt) 1995-12-26
LV11179B (en) 1997-06-20
CN1295072A (zh) 2001-05-16
NO953989L (no) 1995-12-07
PL310997A1 (en) 1996-01-22
US5990132A (en) 1999-11-23
NZ265183A (en) 1997-11-24
HUT74104A (en) 1996-11-28
EP0693069A1 (en) 1996-01-24
SK124695A3 (en) 1996-06-05
AU6554994A (en) 1994-11-08
CA2160112A1 (en) 1994-10-27
NO308745B1 (no) 2000-10-23
AU690906B2 (en) 1998-05-07
PL178570B1 (pl) 2000-05-31

Similar Documents

Publication Publication Date Title
DK0386997T3 (da) Anvendelse af 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamin-derivater i behandlingen af psykose, inflammation og som immunosuppressive midler
ATE198894T1 (de) 1,5 benzodiazepinoderivate mit cck- antagonisierender und oder agonisierender wirkung
EP0682665A4 (en) ANTHRAQUINONE AND ANTHRACENE DERIVATIVES INHIBITING CELL ADHESION MOLECULES OF THE IMMUNE SYSTEM.
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE69705821D1 (de) N-((1,2,4)triazoloazinyl)benzolsulfonamid- und pyridinsulfonamidverbindungen und deren verwendung als herbizide
DE69302863D1 (de) Wässrige Beschichtungszusammensetzung und diese verwendendes Beschichtungsverfahren
NO944686D0 (no) Oppslemming som inneholder titandioksyd og fremgangsmåte for dannelse av oppslemmingen
NO953989D0 (no) Nye polysykliske systemer og derivater derav, som neurotransmitter frigivelses-forsökende midler som er anvendbare ved behandling av kognitive sykdommer
NO308469B1 (no) Triazin-inneholdende anioniske forbindelser egnet som antivirale forbindelser, anvendelse av forbindelsene samt farmasøytisk blanding
ZA942444B (en) Polycyclic systems and derivatives thereof as neurotransmitter release enhancers useful in the treatment of cognitive disorders
FI974640A (fi) Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit
EE03193B1 (et) (1-heteroasolüül-1-heterotsüklüül)alkaani derivaadid, nende saamise protsessid ja nende kasutamine närvisüsteemi kaitsvate vahendite valmistamiseks
BR9400338A (pt) Processo para preparação de 1,1,1,2-tetrafluoro-2-cloroetano e de pentafluoretano
DE69422126D1 (de) Flüssigkristallzusammensetzung, Flüssigkristallvorrichtung und diese verwendende Vorrichtung
TW282455B (no)
DE69417979D1 (de) Polyisocyanat, blockiertes polyisocyanat und beschichtungszusammensetzung
IT1278056B1 (it) Derivati della s-triazina, loro preparazione e loro impiego come assorbenti uv.
BR9711575A (pt) Emprego de 1-hidrÄxi-2-piridonas para o tratamento da dermatite seborr-ica
PT935598E (pt) Derivados de 3-oxo-pirido (1,2-a)benzimidazole-4-carboxamida alquilo substituidos contendo 5 heteroatomos uteis no tratamento de disturbios do sistema nervoso central
ITRM930502A0 (it) Procedimento per la produzione di r amminocarnitina e s amminocarnitina.
EP0615148A3 (de) Verfahren und Vorrichtung zur Polarisation von Licht.
AU6581294A (en) Ethanolamine derivatives useful for the treatment of gastrointestinal disorders
ITRM940140A0 (it) Procedimento e dispositivo per la produzione di potassa.
MA22937A1 (fr) Derives de la n-(phenylethyl-b-ol) amine ainsi que leur procede de preparation .
AU6217694A (en) Use of triazine compounds for the treatment of memory and learning disorders

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN OCTOBER 2001